Article info

Download PDFPDF
Randomised controlled trial
Compared with low-dose losartan, high-dose losartan decreases risk of death or hospital admission for heart failure in people with heart failure who are intolerant to ACE inhibitors

Authors

  1. Correspondence to Robert McKelvie
    David Braley Cardiac, Vascular and Stroke Research Institute, McMaster University and Hamilton Health Sciences, Hamilton General Hospital Campus, 237 Barton Street E, Hamilton, Ontario L8L 2X2, Canada; robert.mckelvie{at}phri.ca
View Full Text

Citation

McKelvie R
Compared with low-dose losartan, high-dose losartan decreases risk of death or hospital admission for heart failure in people with heart failure who are intolerant to ACE inhibitors

Publication history

  • First published May 1, 2010.
Online issue publication 
May 01, 2010

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.